Melt Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Melt Pharmaceuticals's estimated annual revenue is currently $1.2M per year.
- Melt Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Melt Pharmaceuticals has 6 Employees.
- Melt Pharmaceuticals grew their employee count by 20% last year.
Melt Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Financial Officer | Reveal Email/Phone |
3 | Senior Director Clinical Operations | Reveal Email/Phone |
Melt Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.2M | 6 | 20% | N/A | N/A |
#2 | $152.8M | 543 | 0% | $28.5M | N/A |
#3 | $102.7M | 511 | 0% | N/A | N/A |
#4 | $62.1M | 309 | 6% | N/A | N/A |
#5 | $10.1M | 50 | -2% | N/A | N/A |
#6 | $23.7M | 118 | 12% | $23.6M | N/A |
#7 | $5.8M | 29 | 4% | N/A | N/A |
#8 | $14.3M | 71 | 27% | N/A | N/A |
#9 | $15.9M | 79 | 7% | N/A | N/A |
#10 | $8.8M | 44 | 16% | N/A | N/A |
What Is Melt Pharmaceuticals?
Melt Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the development and commercialization of patented non-intravenous and non-opioid sedation and analgesia medicines for short-duration medical procedures in outpatient and in-office settings. Melt’s core technology is a series of combination non-opioid sedation drug formulations that may replace or supplement current sedation modalities for more than 100 million medical procedures in the United States.
keywords:N/AN/A
Total Funding
6
Number of Employees
$1.2M
Revenue (est)
20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 6 | -14% | N/A |
#2 | $0.4M | 6 | 0% | N/A |
#3 | $0.4M | 6 | 20% | N/A |
#4 | $0.4M | 6 | 20% | N/A |
#5 | $0.4M | 6 | 0% | N/A |